Microglia modulate Aβ-dependent astrocyte reactivity in Alzheimer’s disease
Open Access
- 6 November 2025
- journal article
- research article
- Published by Springer Nature in Nature Neuroscience
- Vol. 29 (1) , 81-87
Abstract
Experimental evidence suggests that activated microglia induce astrocyte reactivity in neurodegenerative disorders, such as Alzheimer’s disease (AD). In this study, we investigated the association between microglial activation and amyloid-β (Aβ) with reactive astrogliosis in individuals across the AD spectrum. We examined 101 individuals using positron emission tomography radiotracers to assess Aβ deposition ([18F]AZD4694), tau aggregation ([18F]MK-6240) and microglial activation ([11C]PBR28), along with plasma biomarkers for astrocyte reactivity (GFAP) and tau phosphorylation (p-tau217). We further evaluated 251 individuals with cerebrospinal fluid levels of the microglial marker sTREM2. We found that Aβ pathology was associated with astrocyte reactivity across cortical brain regions only in the presence of microglial activation. The microglia-dependent effects of Aβ on astrocyte reactivity were further related to cognitive impairment through tau phosphorylation and aggregation. Our results suggest that microglial activation plays a key role in Aβ-related astrocyte reactivity, which, in turn, contributes to downstream pathological features of AD.Keywords
All Related Versions
This publication has 77 references indexed in Scilit:
- Revised criteria for diagnosis and staging of Alzheimer's disease: Alzheimer's Association WorkgroupAlzheimer's & Dementia, 2024
- Modeling the temporal evolution of plasma p‐tau in relation to amyloid beta and tau PETAlzheimer's & Dementia, 2023
- Association of Phosphorylated Tau Biomarkers With Amyloid Positron Emission Tomography vs Tau Positron Emission TomographyJAMA Neurology, 2023
- Differences Between Plasma and Cerebrospinal Fluid Glial Fibrillary Acidic Protein Levels Across the Alzheimer Disease ContinuumJAMA Neurology, 2021
- Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer DiseaseJAMA Neurology, 2021
- Development and validation of a high‐sensitivity assay for measuring p217+tau in plasmaAlzheimer's & Dementia: Diagnosis, Assessment & Disease Monitoring, 2021
- An examination of a novel multipanel of CSF biomarkers in the Alzheimer's disease clinical and pathological continuumAlzheimer's & Dementia, 2020
- Exercise as a potential modulator of inflammation in patients with Alzheimer's disease measured in cerebrospinal fluid and plasmaExperimental Gerontology, 2019
- Reactive Glia not only Associates with Plaques but also Parallels Tangles in Alzheimer's DiseaseThe American Journal of Pathology, 2011
- Automated Anatomical Labeling of Activations in SPM Using a Macroscopic Anatomical Parcellation of the MNI MRI Single-Subject BrainNeuroImage, 2002